US Stock MarketDetailed Quotes

COYA Coya Therapeutics

Watchlist
  • 8.430
  • +0.020+0.24%
Close Apr 25 16:00 ET
123.10MMarket Cap-10670P/E (TTM)

Coya Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
6M
6M
0
0
0
0
0
0
0
0
Operating revenue
--6M
--6M
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
43.88%13.36M
147.53%3.99M
41.05%3.56M
-15.72%2.9M
70.56%2.9M
90.68%9.29M
0.96%1.61M
2.53M
3.45M
1.7M
Selling and administrative expenses
61.61%7.83M
164.55%2.38M
58.96%1.96M
-8.28%1.83M
131.57%1.66M
109.64%4.85M
22.74%898.65K
--1.24M
--1.99M
--717.52K
-General and administrative expense
61.61%7.83M
164.55%2.38M
58.96%1.96M
-8.28%1.83M
131.57%1.66M
109.64%4.85M
22.74%898.65K
--1.24M
--1.99M
--717.52K
Research and development costs
24.68%5.5M
127.34%1.61M
24.56%1.59M
-26.21%1.07M
25.84%1.23M
73.57%4.41M
-17.27%708.03K
--1.28M
--1.45M
--978.8K
Depreciation amortization depletion
0.00%27.36K
0.00%6.84K
-45.07%6.84K
69.60%6.84K
69.60%6.84K
69.60%27.36K
-32.86%6.84K
--12.46K
--4.03K
--4.03K
-Depreciation and amortization
0.00%27.36K
0.00%6.84K
-45.07%6.84K
69.60%6.84K
69.60%6.84K
69.60%27.36K
-32.86%6.84K
--12.46K
--4.03K
--4.03K
Operating profit
20.75%-7.36M
224.47%2.01M
-41.05%-3.56M
15.72%-2.9M
-70.56%-2.9M
-90.68%-9.29M
-0.96%-1.61M
-2.53M
-3.45M
-1.7M
Net non-operating interest income expense
Other net income (expense)
103.25%96.18K
98.76%-18.51K
109.51%142.09K
-673.92%-191.03K
5,523.73%163.63K
-13,668.91%-2.96M
-4,638.52%-1.49M
-1.49M
33.29K
-3.02K
Gain on sale of security
----
----
----
----
----
---2.5M
---1.12M
---1.4M
--22.35K
----
Special income (charges)
-3.46%-543.19K
50.47%-193.19K
--0
---350K
----
---525K
---390K
---135K
--0
----
-Less:Other special charges
3.46%543.19K
-50.47%193.19K
----
--350K
----
--525K
--390K
--135K
----
----
Other non- operating income (expenses)
904.14%639.37K
969.64%174.67K
260.45%142.09K
1,353.11%158.97K
5,523.73%163.63K
396.40%63.67K
151.79%16.33K
--39.42K
--10.94K
---3.02K
Income before tax
40.68%-7.26M
164.03%1.99M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
-4.02M
-3.41M
-1.7M
Income tax
723.85K
0
Net income
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
-4.02M
-3.41M
-1.7M
Net income continuous Operations
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
---4.02M
---3.41M
---1.7M
Minority interest income
Net income attributable to the parent company
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
-4.02M
-3.41M
-1.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
34.77%-7.99M
140.74%1.27M
14.89%-3.42M
9.30%-3.1M
-60.65%-2.74M
-150.31%-12.24M
-90.69%-3.11M
-4.02M
-3.41M
-1.7M
Basic earnings per share
83.30%-0.79
146.72%0.15
18.15%-0.34
40.02%-0.31
-8.54%-0.28
-538.47%-4.73
-30.09%-0.3211
-0.4154
-0.5169
-0.258
Diluted earnings per share
83.30%-0.79
146.72%0.15
18.15%-0.34
40.02%-0.31
-8.54%-0.28
-538.47%-4.73
-30.09%-0.3211
-0.4154
-0.5169
-0.258
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 6M6M00000000
Operating revenue --6M--6M--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 43.88%13.36M147.53%3.99M41.05%3.56M-15.72%2.9M70.56%2.9M90.68%9.29M0.96%1.61M2.53M3.45M1.7M
Selling and administrative expenses 61.61%7.83M164.55%2.38M58.96%1.96M-8.28%1.83M131.57%1.66M109.64%4.85M22.74%898.65K--1.24M--1.99M--717.52K
-General and administrative expense 61.61%7.83M164.55%2.38M58.96%1.96M-8.28%1.83M131.57%1.66M109.64%4.85M22.74%898.65K--1.24M--1.99M--717.52K
Research and development costs 24.68%5.5M127.34%1.61M24.56%1.59M-26.21%1.07M25.84%1.23M73.57%4.41M-17.27%708.03K--1.28M--1.45M--978.8K
Depreciation amortization depletion 0.00%27.36K0.00%6.84K-45.07%6.84K69.60%6.84K69.60%6.84K69.60%27.36K-32.86%6.84K--12.46K--4.03K--4.03K
-Depreciation and amortization 0.00%27.36K0.00%6.84K-45.07%6.84K69.60%6.84K69.60%6.84K69.60%27.36K-32.86%6.84K--12.46K--4.03K--4.03K
Operating profit 20.75%-7.36M224.47%2.01M-41.05%-3.56M15.72%-2.9M-70.56%-2.9M-90.68%-9.29M-0.96%-1.61M-2.53M-3.45M-1.7M
Net non-operating interest income expense
Other net income (expense) 103.25%96.18K98.76%-18.51K109.51%142.09K-673.92%-191.03K5,523.73%163.63K-13,668.91%-2.96M-4,638.52%-1.49M-1.49M33.29K-3.02K
Gain on sale of security -----------------------2.5M---1.12M---1.4M--22.35K----
Special income (charges) -3.46%-543.19K50.47%-193.19K--0---350K-------525K---390K---135K--0----
-Less:Other special charges 3.46%543.19K-50.47%193.19K------350K------525K--390K--135K--------
Other non- operating income (expenses) 904.14%639.37K969.64%174.67K260.45%142.09K1,353.11%158.97K5,523.73%163.63K396.40%63.67K151.79%16.33K--39.42K--10.94K---3.02K
Income before tax 40.68%-7.26M164.03%1.99M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M-4.02M-3.41M-1.7M
Income tax 723.85K0
Net income 34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M-4.02M-3.41M-1.7M
Net income continuous Operations 34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M---4.02M---3.41M---1.7M
Minority interest income
Net income attributable to the parent company 34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M-4.02M-3.41M-1.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 34.77%-7.99M140.74%1.27M14.89%-3.42M9.30%-3.1M-60.65%-2.74M-150.31%-12.24M-90.69%-3.11M-4.02M-3.41M-1.7M
Basic earnings per share 83.30%-0.79146.72%0.1518.15%-0.3440.02%-0.31-8.54%-0.28-538.47%-4.73-30.09%-0.3211-0.4154-0.5169-0.258
Diluted earnings per share 83.30%-0.79146.72%0.1518.15%-0.3440.02%-0.31-8.54%-0.28-538.47%-4.73-30.09%-0.3211-0.4154-0.5169-0.258
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg